Preeclampsia
-
A case of puerperial HELLP syndrome complicated by subcapsular liver hematoma
-
A potential role of maternal dietary pattern in the development of preeclampsia
-
Abnormal uterine artery doppler versus laterally located placenta in predicting maternal and neonatal outcomes in preeclampsia
-
Adherence to guideline-recommended aspirin for preeclampsia prevention
-
Aspirin at 75 to 81 mg for the prevention of preterm preeclampsia: a meta-analysis
-
Association of genetic ancestry with preeclampsia in multi-ethnic cohorts of pregnant women
-
Biochemical markers and preeclampsia risk
-
Biochemical markers of cardiac dysfunction in pregnancies with hypertensive pregnancy disorders
-
Correlation between sFlt-1/PIGF ratio levels in patients with severe range blood pressures before 34 weeks of gestation and the mean latency time until delivery
-
Cost analysis of predicting preeclampsia by pro-and-anti angiogenic factors
-
Cytokines and melatonin: their roles and interaction in pregnancy complicated with preeclampsia
-
Development of a tool to assess calcium intake and identify pregnant women at risk of preeclampsia
-
Dietary intake of ultra-processed foods and risk of preeclampsia
-
Effect of aspirin on placental biomarkers profile in women at high-risk for preeclampsia
-
Effect of Mediterranean diet intervention during pregnancy on maternal brain: a secondary analysis of the IMPACT BCN randomized clinical trial
-
Effectiveness of preeclampsia screening - a six month analysis
-
Effects of a Mediterranean diet intervention during pregnancy on the incidence of preeclampsia. The IMPACT BCN trial
-
Effects of mediterranean diet or stress reduction interventions during pregnancy on fetal brain development assessed by MR measurements
-
Evaluation of adherence to aspirin use in the prevention of preeclampsia
-
Evaluation of diagnostic accuracy of sFlt-1: PlGF ratio, uric acid, and the combination of both in preeclampsia spectrum disorders: a retrospective study
-
Evaluation of implementation of a prophylaxis protocol with aspirin 150mg/day on occurrence of preeclampsia, fetal growth restriction, and prematurity
-
Fetal fraction of cell-free DNA in non-invasive prenatal testing and adverse pregnancy outcomes: a retrospective cohort study of 56,110 pregnant women
-
First trimester screening program for preterm preeclampsia and aspirin prophylaxis in an Italian obstetric population
-
First-trimester preeclampsia screening and risk of adverse pregnancy outcome
-
Fisrt trimester screening for preeclampsia
-
Impact of aspirin dose on the development of preeclampsia in twin pregnancy: a multicentre retrospective study with propensity score matching
-
Impact of preeclampsia screening implementation on incidence and outcomes: a hospital-based study
-
Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomised trial in Asia
-
Increased risk of intrapartum fetal compromise in patients at high risk of preeclampsia via the Fetal Medicine Foundation algorithm who do not develop preeclampsia
-
Influence of hypertension in pregnancy on neonatal birthweight
-
Influence of seasonality on preeclampsia in pregnant women assisted at the maternity school of the federal university of Rio de Janeiro, Brazil
-
Inter-manufacturer assessment of the diagnostic performance of angiogenic ratio versus glycosylated fibronectin in women with suspected preeclampsia
-
Maternal cardiovascular hemodynamics for the prediction of preeclampsia at 12-16 weeks
-
Maternal characteristics plus PLGF: a viable alternative approach for 1st trimester PE Screening?
-
Measurement of endothelial dysfunction using the EndoPAT device in pregnant women with preeclampsia and fetal growth restriction
-
Perceived partner support during pregnancy
-
Pilot of community-based point-of-care placental growth factor testing (POC-PlGF) in Sierra Leone
-
PlGF for aspirin discontinuation at 24-28 weeks after preeclampsia screening
-
Postpartum medical care after preeclampsia: an observational database study up to 7.5 years after birth
-
Predicting PE and PTD by extracellular vesicles microarray
-
Prediction of first-trimester preeclampsia in twins by cell-free fetal DNA (cfDNA) fraction, placental growth factor (PLGF), and mean arterial pressure (MAP)
-
Predictive Model for Preeclampsia: sFlt-1/PlGF ratio and uterine artery Doppler parameters
-
Preeclampsia risk prediction model for Chinese pregnant women (ChiPERM): a multicentre, pragmatic, stepped-wedge cluster-randomized controlled trial
-
Prevalence of postpartum hemorrhage in patients on asa 162mg/d for preeclampsia prevention
-
Prevalence of preeclampsia after first trimester screening and prompt prophylaxis intervention at the State Center for Timely Prenatal Screening in León Guanajuato México
-
Retinal findings and risk factors of preeclampsia-associated retinopathy: A retrospective cohort study
-
Role of ophthalmic artery doppler at first trimester in the prediction of preeclampsia
-
Screening and prevention of preeclampsia in patients with preeclampsia and eclampsia admitted to a maternity school in Campina Grande-PB
-
SFlt-1/PlGF ratio in the prediction of preeclampsia in women with diabetic kidney disease (DKD)
-
SFlt/PLGF ratio as a biomarker for adverse maternal and fetal outcomes in hypertensive disorders of pregnancy: an ambispective analysis
-
StopPRE trial: effect of aspirin discontinuation on the trajectories of biophysical and biochemical markers
-
Study protocol for the stepped wedge cluster randomized controlled trial: preeclampsia prevention in denmark (prepred)
-
The association of IL-17 and PlGF/sENG ratio in preeclampsia and adverse pregnancy outcomes
-
The association of severe preeclampsia/eclampsia with adverse maternal and foetal outcomes in Somali women: a cross-sectional study
-
The impact of introducing aspirin before ultrasound at 11-14 weeks in women with previous preeclampsia
-
The prediction model for stillbirth based on first trimester preeclampsia combined screening
-
The use of soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) in differential diagnosis in psychiatric patient suffering from catatonia suspected from eclamptic seizure
-
Timing of a combined first trimester blood-test in screening for chromosomal aberrations and preeclampsia
-
Uterine artery doppler following first-trimester preeclampsia screening
-
Validation of the Full-PIERS model in predicting adverse maternal outcomes in patients with severe early onset preeclampsia in a second level Hospital in the Northeast of Mexico